Stilgenbauer S, Bosch F, Ilhan O, Kisro J, et al. Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study. Br J Haematol 2021;193:325-338.
PMID: 33605445